Skip to main content
. 2020 Nov 11;17(22):8325. doi: 10.3390/ijerph17228325

Table 8.

Assessment of women’s quality of life—categories related to QLQ-BR23 and the time from diagnosis confirmation to treatment.

QLQ-BR23 p Time from Confirmation of the Diagnosis to Treatment
up to 2 Weeks
n = 146
above 2 Weeks up to 2 Months
n = 149
above 2 Months
n = 29
M Me SD M Me SD M Me SD
Functional Scales 1
An image of your own body 0.555 67.72 66.67 31.83 61.91 66.67 33.14 54.02 50.00 37.51
Sexual function 0.738 15.56 0.00 23.20 18.34 0.00 23.23 17.82 0.00 27.43
Sexual satisfaction 0.032 43.48 a 33.33 27.10 45.33 33.33 28.38 77.77 b 83.33 27.22
The prospect of the future 0.428 29.45 33.33 33.11 33.33 33.33 34.44 26.44 0.00 34.94
The scale of the symptoms 2
Side effects of systemic treatment 0.225 31.60 28.57 20.59 29.75 28.57 20.56 39.08 38.09 26.52
Ailments related to the arm 0.002 24.05 a 22.22 19.62 29.60 b 33.33 16.97 31.03 22.22 25.09
Ailments related to the breast 0.024 * 21.92 16.67 18.28 25.11 25.00 18.76 31.61 33.33 20.94
Hair loss 0.086 72.94 100 36.19 66.24 66.67 35.02 56.14 33.33 35.23

M—arithmetic mean, Me—median, SD—standard deviation; * no statistically significant differences were found in the post hock analysis. 1 higher value means a better level of functioning and quality of life (min. 0, max. 100). 2 higher value means greater severity of symptoms (min. 0, max. 100). a, b mean values in different letters differ statistically significantly at p < 0.05.